[Federal Register Volume 86, Number 92 (Friday, May 14, 2021)]
[Notices]
[Pages 26519-26521]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2021-10144]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention

[30Day-21-20PJ]


Agency Forms Undergoing Paperwork Reduction Act Review

    In accordance with the Paperwork Reduction Act of 1995, the Centers 
for Disease Control and Prevention (CDC) has submitted the information 
collection request titled ``Formative Research on Community-Level 
Factors that Promote the Primary Prevention of Adverse Childhood 
Experiences (ACEs) and Opioid Misuse Among Children, Youth, and 
Families in Tribal American Indian and Alaska Native (AI/AN) 
Communities'' to the Office of Management and Budget (OMB) for review 
and approval. CDC previously published a ``Proposed Data Collection 
Submitted for Public Comment and

[[Page 26520]]

Recommendations'' notice on July 2,2020 to obtain comments from the 
public and affected agencies. CDC received three comments related to 
the previous notice. This notice serves to allow an additional 30 days 
for public and affected agency comments.
    CDC will accept all comments for this proposed information 
collection project. The Office of Management and Budget is particularly 
interested in comments that:
    (a) Evaluate whether the proposed collection of information is 
necessary for the proper performance of the functions of the agency, 
including whether the information will have practical utility;
    (b) Evaluate the accuracy of the agencies estimate of the burden of 
the proposed collection of information, including the validity of the 
methodology and assumptions used;
    (c) Enhance the quality, utility, and clarity of the information to 
be collected;
    (d) Minimize the burden of the collection of information on those 
who are to respond, including, through the use of appropriate 
automated, electronic, mechanical, or other technological collection 
techniques or other forms of information technology, e.g., permitting 
electronic submission of responses; and
    (e) Assess information collection costs.
    To request additional information on the proposed project or to 
obtain a copy of the information collection plan and instruments, call 
(404) 639-7570. Comments and recommendations for the proposed 
information collection should be sent within 30 days of publication of 
this notice to www.reginfo.gov/public/do/PRAMain. Find this particular 
information collection by selecting ``Currently under 30-day Review--
Open for Public Comments'' or by using the search function. Direct 
written comments and/or suggestions regarding the items contained in 
this notice to the Attention: CDC Desk Officer, Office of Management 
and Budget, 725 17th Street NW, Washington, DC 20503 or by fax to (202) 
395-5806. Provide written comments within 30 days of notice 
publication.

Proposed Project

    Formative Research on Community-Level Factors that Promote the 
Primary Prevention of Adverse Childhood Experiences (ACEs) and Opioid 
Misuse Among Children, Youth, and Families in Tribal American Indian 
and Alaska Native (AI/AN) Communities--New--National Center for Injury 
Prevention and Control (NCIPC), Centers for Disease Control and 
Prevention (CDC).

Background and Brief Description

    Adverse childhood experiences (ACEs) are preventable, potentially 
traumatic events that occur in childhood (0-17 years) such as 
experiencing violence, abuse, or neglect; witnessing violence in the 
home; and having a family member attempt or die by suicide. There is a 
robust evidence base linking ACEs to a variety of poor health outcomes 
across the life span, including depression, alcohol and substance use 
disorder, and violence perpetration and victimization. The ongoing 
opioid epidemic is a complex and significant public health crisis that 
exposes children to opioid misuse, violence, and other ACEs, and 
challenges the ability of Health and Human Service (HHS) systems to 
mitigate the effects of opioid misuse and ACEs on children and families 
across the U.S. American Indian/Alaska Native (AI/AN) populations 
experience a disproportionate burden of opioid misuse and ACEs, and 
ACE-related health outcomes, including opioid overdose, sexual assault, 
and suicide attempts. The nature and consequences of ACEs in Tribal 
communities is unique because of historical trauma and stark 
socioeconomic disparities. In addition, there are gaps in the provision 
of adequate healthcare.
    This collection addresses critical research gaps and extends 
efforts to prevent violence and other ACEs before they occur and to 
build evidence of effectiveness of community-level strategies and 
approaches at the outer levels of the social ecology to Tribal 
communities. Results from this data collection will be communicated to 
relevant public health officials and community stakeholders in the 
study locations. These local public health officials and community 
stakeholders will use the study results to guide strategies to further 
strengthen their local prevention efforts within their regions.
    Data collection methods used in this qualitative study include 
well-established qualitative methods, including in-depth open-ended 
individual interviews and focus groups. Quantitative methods include 
brief structured surveys. There will be a total of six Tribal 
communities (three urban and three rural) in regions identified with 
higher opioid overdose mortality rates relative to other areas in 
Indian Country. Due to COVID-19, at the time of the focus groups/
interviews, social distancing and public health safety measures will be 
implemented, including considerations for phone/virtual meetings 
instead of in-person sessions.
    The total estimated annualized burden hours are 441. There are no 
costs to respondents other than their time.

                                                            Estimated Annualized Burden Hours
--------------------------------------------------------------------------------------------------------------------------------------------------------
                                                                                                                             Number of    Average burden
              Type of respondents                                       Form name                            Number of     responses per   per response
                                                                                                            respondents     respondent      (in hours)
--------------------------------------------------------------------------------------------------------------------------------------------------------
Adults 18 years or older affected by the        Information Letter......................................             160               1            5/60
 opioid epidemic (e.g., parents/caregivers of   Telephone screening.....................................             160               1           25/60
 AI/AN children, Tribal Elders) living in       Confirmation email/letter...............................
 Tribal urban and rural/reservation
 communities.
                                                ........................................................             120               1            5/60
                                                Reminder email..........................................             120               1            5/60
                                                Informed Consent........................................             120               1           25/60
                                                Demographic Survey......................................             120               1           25/60
                                                Focus group/interview...................................              44               1               2
                                                Focus group/interview...................................              64               1               2
                                                Focus group/interview...................................              12               1               2
--------------------------------------------------------------------------------------------------------------------------------------------------------



[[Page 26521]]

Jeffrey M. Zirger,
Lead, Information Collection Review Office, Office of Scientific 
Integrity, Office of Science, Centers for Disease Control and 
Prevention.
[FR Doc. 2021-10144 Filed 5-13-21; 8:45 am]
BILLING CODE 4163-18-P